Drug Research
University of Kent research identifies novel Covid-19 therapy
Researchers have identified a potential new treatment that suppresses the replication of SARS-CoV-2, the coronavirus that causes Covid-19.
In order to multiply, all viruses, including coronaviruses, infect cells and reprogramme them to produce novel viruses. The research revealed that cells...
News
Cryoviva Singapore Gets AABB Accreditation for Somatic Cells Processing, Storage, and Distribution
Family cord blood bank Cryoviva Singapore is pleased to announce that it has now been accredited by the Association of the Advancement of Blood & Biotherapies (AABB), formerly known as the American Association of Blood Banks, for both cord...
News
End-to-End Multi-Attribute Method Solution Accelerates Biotherapeutic Development and Manufacturing
Biopharmaceutical laboratories working across R&D, manufacturing and quality control (QC) environments can now streamline biopharmaceutical characterization, process monitoring and release testing using a new seamless, built-for-purpose multi-attribute method (MAM) workflow.
The Thermo Scientific MAM 2.0 workflow is a culmination of...
News
Australia Approves Covid Vaccine Booster Shots For 18 And Above
Australia on Wednesday authorised booster shots of Covid-19 vaccines for over-18s, with the third dose expected to be offered to the entire population from next month.
The Therapeutic Goods Administration regulatory authority said it had granted provisional approval for one...
News
Russia approves Sputnik V Covid-19 vaccination with flu shot
The Health Ministry of Russia has reportedly granted approval for administering Covid-19 vaccine Sputnik V and flu shots simultaneously, making changes to the instruction for the vaccine use.
Studies have demonstrated that the joint administration of both vaccines has not...
Drug Research
BioNTech Plans to Initiate the Construction of an mRNA Vaccine Manufacturing Facility in Africa in mid-2022
BioNTech SE announced that the Company plans to initiate the construction of the first state-of-the-art manufacturing site for mRNA-based vaccines in the African Union in mid-2022. This is the next step in BioNTech’s efforts to implement sustainable end-to-end vaccine...
News
Abzena Promotes Dr. Louise Duffy as Chief Technical Officer
Abzena, the leading Partner Research Organization (PRO) for outsourced solutions integrating gene to commercial for large molecules and bioconjugates, announced it has promoted Dr. Louise Duffy as Chief Technical Officer.
Reporting to Kimball Hall, President and Chief Operating Officer, and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















